Literature DB >> 20558422

Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis--case series.

P M K Tam, A L Young, L L Cheng, P T H Lam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558422     DOI: 10.1136/bjo.2009.172387

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

Review 1.  Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.

Authors:  Pakit Vichyanond; Panida Kosrirukvongs
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

Review 2.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

3.  Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients.

Authors:  Kyungmin Koh; Ikhyun Jun; Tae-Im Kim; Eung Kweon Kim; Kyoung Yul Seo
Journal:  BMC Ophthalmol       Date:  2021-06-05       Impact factor: 2.209

Review 4.  Topical tacrolimus in anterior segment inflammatory disorders.

Authors:  Samir S Shoughy
Journal:  Eye Vis (Lond)       Date:  2017-03-09

5.  Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.

Authors:  Abdulrahman M Al-Amri; Aleem Gulzar Mirza; Ahmed Mossa Al-Hakami
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jan-Mar

6.  Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis.

Authors:  Abdulrahman Mohammed Al-Amri; Sandra Flavia Fiorentini; Maan A Albarry; Ashjan Yousef Bamahfouz
Journal:  Oman J Ophthalmol       Date:  2017 Sep-Dec

7.  Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East.

Authors:  Sandra Flavia Fiorentini; Darakhshanda Khurram
Journal:  Saudi J Ophthalmol       Date:  2019-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.